Management of patients with herpes simplex virus eye disease having cataract surgery in the United Kingdom
Published: 1 August 2013
Journal of Cataract and Refractive Surgery , Volume 39, pp 1254-1259; https://doi.org/10.1016/j.jcrs.2013.06.005
Abstract: To standardize the management of patients with herpetic eye disease scheduled for cataract surgery, a questionnaire was sent to each fellow of the Royal College of Ophthalmologists registered as a consultant with a subspecialty interest in cornea. Most respondents agreed that disease stability was required before cataract surgery was offered; 62.3% would operate on patients in whom the disease had been quiescent for 3 to 6 months. The decision to prescribe prophylactic antivirals divided the respondents, with 58.8% in favor of starting antiviral treatment. Most respondents (72.46%) did not start topical antiviral treatment. In regard to changing topical steroid use postoperatively, 80.9% would not change their routine regimen. Oral acyclovir was the first line of treatment for 92.5%. The conclusions were that a significant period of inactivity should be considered before cataract surgery is performed in patients with herpes simplex virus eye disease. Oral antiviral prophylaxis is common clinical practice, but no change in routine postoperative steroid use is needed. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.
Keywords: antiviral / virus / cataract surgery / treatment / prophylaxis / simplex / herpes / eye
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Journal of Cataract and Refractive Surgery" .